Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Value of 18F -Fluorocholine (18F-FCH) PET in Localizing Parathyroid Lesions: Comparison With 99mTc-sestamibi (MIBI) Scan.

NCT03555487 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03555487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03555487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Value of 18F -Fluorocholine (18F-FCH) PET in Localizing Parathyroid Lesions: Comparison With 99mTc-sestamibi (MIBI) Scan.
Lead sponsor
National Taiwan University Hospital
Phase
Phase 3
Overall status
Completed
Start date
May 5, 2015
Completion date
October 1, 2018
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parathyroid diseases